Baseline laboratory values, by sex
| Laboratory values | Overall cohort (n=1886) | Females (n=437) | Males (n=1449) | p Value |
|---|---|---|---|---|
| AFP (n=1478) | 41 (1–7 400 000) | 60 (1–7 400 000) | 38 (1–1 194 376) | 0.05 |
| HGB (n=1417) | 13.2 (4.7 to 18) | 12.5 (4.7 to 16.1) | 13.5 (5.2 to 18) | <0.0001 |
| PLT (n=1689) | 119 (17–693) | 111 (28–693) | 123 (17–664) | 0.09 |
| CR (n=1661) | 0.93 (0.39–8.5) | 0.8 (0.4–6.8) | 1 (0.39–8.5) | <0.0001 |
| TB (n=1696) | 1.1 (0–41.4) | 1.1 (0.2–25.8) | 1.2 (0–41.4) | 0.08 |
| ALB (n=1677) | 3.3 (0.5–5) | 3.3 (1.1–4.5) | 3.3 (0.5-5) | 0.25 |
| ALT (n=1540) | 66 (6–1349) | 60 (13–458) | 68 (6–1349) | 0.006 |
| AST (n=1547) | 82 (12–2198) | 79 (12–1076) | 83 (14–2198) | 0.30 |
| INR (n=1529) | 1.2 (0.7–6.1) | 1.2 (0.9–6.1) | 1.2 (0.7–5.5) | 0.22 |
| MELD (n=1461) | 10.3 (6.4–50.2) | 10.2 (6.4–50.2) | 10.3 (6.4–45.4) | 0.21 |
| CPT (n=1450) | 0.79 | |||
| Class A | 718 (49.5%) | 163 (48.1%) | 555 (50.0%) | |
| Class B | 556 (38.3%) | 132 (38.9%) | 424 (38.2%) | |
| Class C | 176 (12.2%) | 44 (13.0%) | 132 (11.9%) |
Bolded p values indicate significant difference (p<0.05).
AFP, α-fetoprotein; ALB, albumin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; CPT, Child-Pugh-Turcotte score; CR, creatinine; DM, diabetes mellitus; GI, gastrointestinal; HGB, haemoglobin; HTN, hypertension; INR, international normalised ratio; MELD, Model for End-Stage Liver Disease; PLT, platelet; TB, tuberculosis.